Literature DB >> 19928356

Tissue-specific tumour suppression by APC.

Owen Sansom1.   

Abstract

One question that has been central to the study of the Apc gene is why the Apc gene is mutated so frequently in colorectal cancer but relatively infrequently in other tumour types. This chapter reviews recent data obtained in mice after conditional deletion of both copies of the Apc gene from adult epithelial tissues with particular focus on the intestinal epithelium. These data suggest that a major reason for the frequent mutation of Apc in colorectal cancer lies in the distinct character of the intestinal epithelium where Apc loss leads to a progenitor-like phenotype. Thus intestinal enterocytes lacking Apc escape the two major selective constraints that usually prevent cells from becoming cancerous in the intestine: they fail to differentiate and fail to migrate so are not sloughed off into the intestinal lumen.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19928356

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  4 in total

1.  The CRM1 nuclear export protein in normal development and disease.

Authors:  Kevin T Nguyen; Michael P Holloway; Rachel A Altura
Journal:  Int J Biochem Mol Biol       Date:  2012-05-18

Review 2.  More than two decades of Apc modeling in rodents.

Authors:  Maged Zeineldin; Kristi L Neufeld
Journal:  Biochim Biophys Acta       Date:  2013-01-17

Review 3.  The mini-driver model of polygenic cancer evolution.

Authors:  Francesc Castro-Giner; Peter Ratcliffe; Ian Tomlinson
Journal:  Nat Rev Cancer       Date:  2015-10-12       Impact factor: 60.716

4.  Cortactin promotes colorectal cancer cell proliferation by activating the EGFR-MAPK pathway.

Authors:  Xiaojian Zhang; Kun Liu; Tao Zhang; Zhenlei Wang; Xuan Qin; Xiaoqian Jing; Haoxuan Wu; Xiaopin Ji; Yonggang He; Ren Zhao
Journal:  Oncotarget       Date:  2017-01-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.